NVS
Novartis (NVS) Q1 2026 Earnings
NVS·Reported April 28, 2026·Before market open
Novartis reported Q1 2026 revenue of $13.1B (-3.7% YoY), missed analyst consensus of $13.4B by $325.4M. Diluted EPS came in at $1.99 (-12.7% YoY), missed the $2.11 consensus by $0.12.
Revenue
$13.1Bmissed by $325.4M
Consensus: $13.4BDiluted EPS
$1.99missed by $0.12
Consensus: $2.11
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2026 Earnings FAQ
Common questions about Novartis's Q1 2026 earnings report.
Novartis (NVS) reported Q1 2026 earnings on April 28, 2026 before market open.
Novartis reported revenue of $13.1B and diluted EPS of $1.99 for Q1 2026.
Revenue missed the consensus estimate of $13.4B by $325.4M. EPS missed the consensus estimate of $2.11 by $0.12.
Compared to the same quarter a year prior, revenue declined 3.7% from $13.6B a year earlier and diluted EPS declined 12.7% from $2.28.